发明授权
US07579158B2 Cellular retinoic acid binding protein II as a marker for breast cancer
失效
细胞视黄酸结合蛋白II作为乳腺癌的标志物
- 专利标题： Cellular retinoic acid binding protein II as a marker for breast cancer
- 专利标题（中）： 细胞视黄酸结合蛋白II作为乳腺癌的标志物
-
申请号： US11294176申请日： 2005-12-05
-
公开(公告)号： US07579158B2公开(公告)日： 2009-08-25
- 发明人: Gabriele Pestlin , Herbert Andres , Peter Berndt , Marie-Luise Hagmann , Johann Karl , Hanno Langen , Werner Zolg
- 申请人： Gabriele Pestlin , Herbert Andres , Peter Berndt , Marie-Luise Hagmann , Johann Karl , Hanno Langen , Werner Zolg
- 申请人地址： US IN Indianapolis
- 专利权人： Roche Diagnostics Operations, Inc.
- 当前专利权人： Roche Diagnostics Operations, Inc.
- 当前专利权人地址： US IN Indianapolis
- 代理机构： Roche Diagnostics Operations, Inc.
- 代理商 Marilyn L. Amick
- 优先权： EP03012942 20030606
- 主分类号： G01N33/53
- IPC分类号： G01N33/53 ; G01N33/68 ; G01N33/96 ; G01N33/574
摘要：
The present invention relates to the diagnosis of breast cancer. It discloses the use of protein cellular retinoic acid binding protein II in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring cellular retinoic acid binding protein II in said sample. Measurement of cellular retinoic acid binding protein II can, e.g., be used in the early detection or diagnosis of breast cancer.